Wealth Quarterback LLC United Therapeutics Corp Transaction History

Wealth Quarterback LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $549,427 - $757,903	-3,143 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$179.86 - $214.88 $560,084 - $669,136	3,114 Added 10737.93%	3,143 $2,000
Q2 2021 Aug 11, 2021	BUY	$170.47 - $211.93 $4,943 - $6,145	29 New	29 $6,000
Q2 2020 Aug 17, 2020	SELL	$92.74 - $125.82 $2,689 - $3,648	-29 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$78.31 - $95.34 $2,270 - $2,764	29 New	29 $2,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.